Interchangeability of the Assays Used to Assess the Activity of Anti-SARS-CoV-2 Monoclonal Antibodies

The recent global COVID-19 pandemic caused by SARS-CoV-2 lasted for over three years. A key measure in combatting this pandemic involved the measurement of the monoclonal antibody (mAb)-mediated inhibition of binding between the spike receptor-binding domain (RBD) and hACE2 receptor. Potency assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickerson, Brady T., Khalenkov, Alexey M., Xie, Tao, Frucht, David M., Scott, Dorothy E., Ilyushina, Natalia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459467/
https://www.ncbi.nlm.nih.gov/pubmed/37632039
http://dx.doi.org/10.3390/v15081698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459467/
https://www.ncbi.nlm.nih.gov/pubmed/37632039
http://dx.doi.org/10.3390/v15081698

Ejemplares similares